Gilad Oren
SEC insider (Form 3/4/5 filer). CIK 0001929300. President/CEO at Aprea Therapeutics, Inc. (APRE). 11 reported Form 4/5 transactions since Sep 2024; latest on Mar 12, 2026. Located in DOYLESTOWN, PA.
Companies Gilad Oren has filed insider reports for
- Aprea Therapeutics, Inc. (APRE): Director, Officer, President/CEO
Gilad Oren
CIK: 0001929300
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aprea Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Mar 12, 2026APRE
Aprea Therapeutics, Inc.
AwardDirect20.2K shares- - Jan 30, 2026APRE
Aprea Therapeutics, Inc.
PurchaseDirect28.1K shares at avg. $0.89$25K - Dec 10, 2025APRE
Aprea Therapeutics, Inc.
PurchaseDirectCommon Warrants
21.5K shares- - Dec 10, 2025APRE
Aprea Therapeutics, Inc.
PurchaseDirectPre-Funded Warrant
21.5K shares at avg. $1.17- - Apr 3, 2025APRE
Aprea Therapeutics, Inc.
PurchaseDirect3K shares at avg. $1.87$6K - Apr 3, 2025APRE
Aprea Therapeutics, Inc.
PurchaseDirect2.5K shares at avg. $1.80$4K - Mar 27, 2025APRE
Aprea Therapeutics, Inc.
AwardDirect6.7K shares- - Oct 23, 2024APRE
Aprea Therapeutics, Inc.
PurchaseDirect500 shares at avg. $3.92$2K - Oct 15, 2024APRE
Aprea Therapeutics, Inc.
PurchaseDirect250 shares at avg. $2.90$725 - Oct 14, 2024APRE
Aprea Therapeutics, Inc.
PurchaseDirect1K shares at avg. $2.59$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 12, 2026 | APRE Aprea Therapeutics, Inc. | Award | 20,175 | - | $0 | Direct |
| Jan 30, 2026 | APRE Aprea Therapeutics, Inc. | Purchase | 28,100 | $0.89 | $25,009 | Direct |
| Dec 10, 2025 | APRE Aprea Therapeutics, Inc. | Purchase Common Warrants | 21,459 | - | - | Direct |
| Dec 10, 2025 | APRE Aprea Therapeutics, Inc. | Purchase Pre-Funded Warrant | 21,459 | $1.17 | - | Direct |
| Apr 3, 2025 | APRE Aprea Therapeutics, Inc. | Purchase | 3,003 | $1.87 | $5,616 | Direct |
| Apr 3, 2025 | APRE Aprea Therapeutics, Inc. | Purchase | 2,497 | $1.80 | $4,495 | Direct |
| Mar 27, 2025 | APRE Aprea Therapeutics, Inc. | Award | 6,725 | - | - | Direct |
| Oct 23, 2024 | APRE Aprea Therapeutics, Inc. | Purchase | 500 | $3.92 | $1,958 | Direct |
| Oct 15, 2024 | APRE Aprea Therapeutics, Inc. | Purchase | 250 | $2.90 | $725 | Direct |
| Oct 14, 2024 | APRE Aprea Therapeutics, Inc. | Purchase | 1,000 | $2.59 | $2,590 | Direct |
1-10 of 11 transactions